CTKB
Cytek Biosciences Inc
NASDAQ: CTKB · HEALTHCARE · MEDICAL DEVICES
$4.56
+2.70% today
Updated 2026-04-30
Market cap
$565.62M
P/E ratio
—
P/S ratio
2.81x
EPS (TTM)
$-0.52
Dividend yield
—
52W range
$2 – $6
Volume
0.7M
Cytek Biosciences Inc (CTKB) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $70.36M | $219.98M | $463.31M | $519.48M | $494.46M | $499.50M |
| Cash & equivalents | $30.12M | $165.23M | $364.62M | $296.60M | $167.30M | $98.72M |
| Current assets | $67.77M | $208.62M | $431.73M | $454.02M | $392.06M | $396.45M |
| Total liabilities | $112.06M | $236.01M | $57.92M | $93.93M | $101.39M | $103.76M |
| Current liabilities | $21.04M | $26.54M | $33.18M | $49.04M | $56.23M | $67.66M |
| Long-term debt | — | — | — | $2.27M | $1.65M | $1.05M |
| Shareholder equity | $-41.70M | $-16.03M | $405.04M | $425.30M | $393.06M | $395.74M |
| Retained earnings | $-42.02M | $-22.61M | $-19.61M | $-17.03M | $-29.18M | $-35.20M |
| Accounts receivable | $17.75M | $18.10M | $29.63M | $50.88M | $56.12M | $60.59M |
| Inventory | $18.43M | $23.02M | $32.17M | $48.15M | $60.88M | $43.89M |
| Goodwill | $476000.00 | $476000.00 | $10.14M | $10.14M | $16.18M | $16.66M |